In 6 SLE patients, the proportion of CD4+Foxp3+ T cells was significantly decreased after immunosuppressive treatment, which resulted in a reduction in SLEDAI (P < 0.01) (Fig. 2). Here, FOXP3 is linked to systemic lupus erythematosus.